Treatment outcomes between bypass surgery and endovascular therapy in patients with chronic limb-threatening ischemia classified as bypass-preferred category based on Global Vascular Guidelines
Koichi Morisaki(Kyushu University), Tomoharu Yoshizumi(Kyushu University), Yutaka Matsubara(Kyushu University), Atsushi Guntani(Saiseikai Yahata General Hospital), Kimihiro Komori(Saiseikai Yahata General Hospital), Shogo Kawanami(Kyushu University), Tadashi Furuyama(Kyushu University), Daisuke Matsuda(Taisho Pharmaceutical (Japan)), Shinsuke Mii, Sho Yamashita(Saiseikai Yahata General Hospital), Kenichi Honma(Matsuyama Red Cross Hospital), Terutoshi Yamaoka(Matsuyama Red Cross Hospital), Go Kinoshita(Kyushu University)
Cited by 15
Related Papers
Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
|European Journal of Vascular and Endovascular Surgery|2019|1.5k
Angiogenic Gene Therapy for Experimental Critical Limb Ischemia
|Circulation Research|2002|238
Impact of Des-Gamma-Carboxy Prothrombin and Tumor Size on the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation
|Transplantation|2009|177
Feasibility of Left Lobe Living Donor Liver Transplantation Between Adults: An 8-Year, Single-Center Experience of 107 Cases
|American Journal of Transplantation|2006|176